Table Of Contents
Key Information 1
Key Ratios 1
Share Data 1
Performance Chart 1
Table Of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Business Description 4
Major Products and Services 4
Overview 4
History 5
SWOT Analysis Overview 6
Overview 6
GENTIUM S.p.A. - Strengths 6
Focused Research and Development Activities 6
Focus on Emerging Therapeutic Segments 6
GENTIUM S.p.A. - Weaknesses 6
History of Operating Losses 6
GENTIUM S.p.A. - Opportunities 6
Biotech Focus 6
Defibrotide in Phase III 6
Licensing and Distribution Agreements 7
GENTIUM S.p.A. - Threats 7
Stiff Competition 7
Tightening of FDA’s Regulatory Oversight 7
Emergence of Generic Products 7
Key Competitors 8
Key Employees 8
Key Employee Biographies 8
Locations And Subsidiaries 9
Head Office 9
Financial Ratios 10
Capital Market Ratios 10
Annual Ratios 10
Interim Ratios 11
Ratio Charts 12
Appendix 13
Methodology 13
Ratio Definitions 13
About Global Markets Direct 16
Contact Us 16
Disclaimer 16


List of Tables
GENTIUM S.p.A., Key Facts 1
GENTIUM S.p.A., Key Ratios 1
GENTIUM S.p.A., Share Data 1
GENTIUM S.p.A., Key Facts 4
GENTIUM S.p.A., History 5
GENTIUM S.p.A., Key Employees 8
GENTIUM S.p.A., Key Employee Biographies 8
GENTIUM S.p.A., Ratios based on current share price 10
GENTIUM S.p.A., Annual Ratios 10
GENTIUM S.p.A., Interim Ratios 11
Currency Codes 13
Capital Market Ratios 13
Equity Ratios 14
Profitability Ratios 14
Cost Ratios 14
Liquidity Ratios 15
Leverage Ratios 15
Efficiency Ratios 15


List of Figures
GENTIUM S.p.A., Performance Chart (2004 - 2008) 1
GENTIUM S.p.A., Ratio Charts 12

Purchase Information